🔎 Trials Near Me

Akèy › Kansè (tout kalite) › Ohio › Akron

Etid klinik pou Kansè (tout kalite) nan Akron, OH

13 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Akron (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Ap rekriteFaz 3
  • Investigative Site, Canton · 21 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06881992

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Ap rekriteFaz 1/2
  • GSK Investigational Site, Canton · 21 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07213609

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Ap rekriteFaz 3
  • Gabrail Cancer & Research Center, Canton · 21 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06072612

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Children's Hospital Medical Center of Akron, Akron
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

International Rare Brain Tumor Registry

Ap rekriteEtid obsèvasyon
  • Akron Children's Hospital, Akron
Jiska laj 45 · Tout sèks · Mizajou Aug 7, 2026 · NCT05697874

Molecular Genetics Studies of Cancer Patients and Their Relatives

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Aultman Health Foundation, Canton · 21 mi lwen
Tout laj · Tout sèks · Mizajou Jun 29, 2026 · NCT04185935

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Ap rekriteFaz 2
  • Gabrail Cancer and Research Center, Canton · 21 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT06463665

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

Ap rekriteEtid obsèvasyon
  • Aultman Medical Group, Canton · 21 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Feb 24, 2026 · NCT06207032

GEMINI-NSCLC: NSCLC Biomarker Study

Ap rekriteEtid obsèvasyon
  • Aultman Hospital, Canton · 21 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT05236114

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Ap rekriteFaz 1
  • Gabrail Cancer & Research Center, Canton · 21 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT05856981

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

Ap rekriteFaz 1/2
  • Gabrail Cancer Center Research, Canton · 21 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 24, 2025 · NCT06228326

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Gabrail Cancer Center Research, Canton · 21 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 18, 2025 · NCT05970497

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Ap rekriteEtid obsèvasyon
  • Aultman Hospital, Canton · 21 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2025 · NCT05234177

Etid Kansè (tout kalite) nan lòt vil

Lòt etid nan Akron

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.